New Hampshire Trust

Position in NVS — Novartis AG

CIK 1961742 CONCORD, NH

Position in NVS

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$1,123,681

+$27,853 QoQ

Shares Held

7,170

-0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

#585

of 1,603 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

New Hampshire Trust holds $23,591,468 across 9 Drug Manufacturers - General names. NVS ranks #4 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	33,795	$8,504,172
2	MRK	Merck & Co., Inc.	54,175	$6,961,487
3	JNJ	Johnson & Johnson	15,285	$3,881,930
4	NVS	Novartis AG This page	7,170	$1,123,681
5	LLY	ELI LILLY & Co	933	$1,119,067
6	AMGN	Amgen Inc	2,237	$810,062
7	BMY	Bristol Myers Squibb Co	9,927	$571,992
8	PFE	Pfizer Inc	16,564	$398,861

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,123,681	7,170	-0.1%	Shares	Defined	2026-07-27
2026-03-31	$1,095,828	7,174	-12.7%	Shares	Defined	2026-04-20
2025-12-31	$1,133,566	8,222	-19.3%	Shares	Defined	2026-01-29
2025-09-30	$1,306,508	10,188	+7.4%	Shares	Defined	2025-10-16
2025-06-30	$1,147,537	9,483	+8.6%	Shares	Defined	2025-07-31
2025-03-31	$973,665	8,734	+4.3%	Shares	Defined	2025-04-08
2024-12-31	$814,873	8,374	-1.6%	Shares	Defined	2025-01-16
2024-09-30	$978,934	8,511	-0.6%	Shares	Defined	2024-10-17
2024-06-30	$911,722	8,564	-11.0%	Shares	Defined	2024-07-15
2024-03-31	$930,832	9,623	-5.4%	Shares	Defined	2024-04-09
2023-12-31	$1,027,571	10,177	-7.9%	Shares	Defined	2024-01-12
2023-09-30	$1,126,061	11,055	-1.9%	Shares	Defined	2023-10-17
2023-06-30	$1,136,750	11,265	-0.7%	Shares	Defined	2023-07-11
2023-03-31	$1,043,188	11,339	-2.8%	Shares	Sole	2023-04-18
2022-12-31	$1,057,885	11,661	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.